Landscapes / Companies
RayzeBio, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials
Trials
6 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor and 16 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2030Phase 1/2 trial completes | |||
| Next date | Jun 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma (HCC) | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2027Phase 1 trial completes | |||
| Next date | Feb 2027 · Phase 1 trial completes | ||||
| Also tested for | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor and 7 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021